Protein and Phospholipid Analysis of HDL in Patients With Very High Serum Levels of HDL-C

Stopped early

Conditions studied: Hyperlipidemia

In brief

Coronary heart disease (CHD) is the single leading cause of death in the United States . Serum Cholesterol is known to have a direct impact on a number of human diseases through a variety of mechanisms. This is particularly true of cardiovascular disease. Measurement and manipulation of serum cholesterol has become a primary focus of primary care physicians and cardiologists when attempting to reduce risk of heart disease.

Key facts

Study ID

NCT00525083

Run by

Vanderbilt University Medical Center

People needed

19

Starts

2005-06-01

Expected to finish

2014-11-03

Last updated by the study team

2017-04-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age > 18 years.
• Serum HDL-C > 100 mg/dL.

You may not qualify if…

• Significant history of smoking.
• Diabetes Mellitus.
• Severe hypertension.
• Age > 65 years

Where it is running

• Vanderbilt University Medical Center — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.